SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Erasca, Inc. ERAS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Erasca, Inc. (ERAS) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ARVN, BDTX, CCCC, CGEM, DSGN, EWTX 等.

ERAS 的市值为 $5.66B, 而同行平均市值为 $950.41M. ERAS 显著大于其平均同行.

同行与相似公司 — ERAS

$10.97 -0.27% $704.54M

Black Diamond Therapeutics, Inc.

$2.87 +7.89% $164.42M

C4 Therapeutics, Inc.

$2.89 +4.90% $239.37M

Cullinan Oncology, Inc.

$14.95 +4.18% $904.87M

Design Therapeutics, Inc.

$12.75 +0.87% $786.32M

Edgewise Therapeutics, Inc.

$33.70 +1.63% $3.62B

Monte Rosa Therapeutics, Inc.

$18.23 +4.17% $1.19B

Gracell Biotechnologies Inc.

$10.25 +0.05% $197.97M

Century Therapeutics, Inc.

$2.59 +9.28% $224.21M

Keros Therapeutics, Inc.

$11.71 +1.39% $435.86M

aTyr Pharma, Inc.

$14.77 +0.54% $928.41M

Mineralys Therapeutics, Inc.

$30.42 +11.35% $2.02B

其他人也在看

Edgewise Therapeutics, Inc.

Relay Therapeutics, Inc.

Stoke Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Olema Pharmaceuticals, Inc.

Monte Rosa Therapeutics, Inc.

aTyr Pharma, Inc.

Sana Biotechnology, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言